Clinical Trial Update: Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether gel aromatherapy reduces pain in patients with De Quervain's tenosynovitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• De Quervain Tenosynovitis

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: De Quervain Disease | Phase 4 | Status: RECRUITING